News
09-29-2009, 04:21 AM
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.
More... (http://www.medicalnewstoday.com/articles/165466.php)
More... (http://www.medicalnewstoday.com/articles/165466.php)